Skip to main content
Home
Issues
2023
June 2023 - Vol 16 No 1
2022
December - Vol 15 No 4
September - Vol 15 No 3
June - Vol 15 No 2
March - Vol 15 No 1 - Online Only
Issue Archive
Special Issues
December 2023 Vol 16, Payers' Guide to FDA Updates
Supplements
Special Issue Archive
Topics
Conference Correspondent
ESMO 2023 - Small Cell Lung Cancer
Web Exclusives
Web Exclusive Topics
All Web Exclusives
Select Drug Profiles
FDA Approvals
In the News
Press Releases
Videos
Interview with the Innovators
About
About AHDB
Contact Us
Permissions
Editorial Policies
Editorial Board
Editorial Process
Advertising Contacts
Advertising Policy
Reprints
Subscribe
Home
Issues
2023
June 2023 - Vol 16 No 1
2022
December - Vol 15 No 4
September - Vol 15 No 3
June - Vol 15 No 2
March - Vol 15 No 1 - Online Only
Issue Archive
Special Issues
December 2023 Vol 16, Payers' Guide to FDA Updates
Supplements
Special Issue Archive
Topics
Conference Correspondent
ESMO 2023 - Small Cell Lung Cancer
Web Exclusives
Web Exclusive Topics
All Web Exclusives
Select Drug Profiles
FDA Approvals
In the News
Press Releases
Videos
Interview with the Innovators
About
About AHDB
Contact Us
Permissions
Editorial Policies
Editorial Board
Editorial Process
Advertising Contacts
Advertising Policy
Reprints
August 2012 Vol 5, No 5, Special Issue ASCO 2012 Payers' Perspective
The Cost of Lung Cancer at the End of Life: Early Institution of Palliative Care Improves Survival
Caroline Helwick
Read More
Why Hasn’t Genomic Testing Changed the Landscape?
Caroline Helwick
Read More
Radiotherapy-Related Hospital Admissions Are Frequent
Read More
Metastatic Colorectal Cancer: Prolonged Bevacizumab Improves Outcomes, New Targeted Therapies on the Horizon
Caroline Helwick
Read More
Patients Willing to Pay for Genetic Testing to Assess Cancer Risk
Read More
Renal-Cell Carcinoma
Axitinib Dose Titration Up Enhances Outcomes in Metastatic Renal-Cell Carcinoma
Wayne Kuznar
Read More
Is Biomarker Testing in NSCLC Cost-Effective?
Caroline Helwick
Read More
Lung Cancer
Non–Small-Cell Lung Cancer Testing Can Be Offered Routinely in Community Hospitals
Wayne Kuznar
Read More
Renal-Cell Carcinoma
Quality of Life Drives Patient Preference for Metastatic RCC Drug
Wayne Kuznar
Read More
Lung Cancer
Afatinib Boosts PFS in EGFR Mutation–Positive Lung Cancer
Wayne Kuznar
Read More
1
2
3
4
Page 3 of 4
Results 21 - 30 of 33